Cargando…

A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI

As patient breathing irregularities can introduce a large uncertainty in targeting the internal tumor volume (ITV) of lung cancer patients, and thereby affect treatment quality, this study evaluates dose tolerance of tumor motion amplitude variations in ITV-based volumetric modulated arc therapy (VM...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guang, Sehovic, Admir, Xu, Lee, Shukla, Pawas, Zhang, Lei, Zhou, Ying, Wang, Ping, Wu, Abraham, Rimner, Andreas, Zhang, Pengpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784418/
https://www.ncbi.nlm.nih.gov/pubmed/36556006
http://dx.doi.org/10.3390/jcm11247390
_version_ 1784857806974746624
author Li, Guang
Sehovic, Admir
Xu, Lee
Shukla, Pawas
Zhang, Lei
Zhou, Ying
Wang, Ping
Wu, Abraham
Rimner, Andreas
Zhang, Pengpeng
author_facet Li, Guang
Sehovic, Admir
Xu, Lee
Shukla, Pawas
Zhang, Lei
Zhou, Ying
Wang, Ping
Wu, Abraham
Rimner, Andreas
Zhang, Pengpeng
author_sort Li, Guang
collection PubMed
description As patient breathing irregularities can introduce a large uncertainty in targeting the internal tumor volume (ITV) of lung cancer patients, and thereby affect treatment quality, this study evaluates dose tolerance of tumor motion amplitude variations in ITV-based volumetric modulated arc therapy (VMAT). A motion-incorporated planning technique was employed to simulate treatment delivery of 10 lung cancer patients’ clinical VMAT plans using original and three scaling-up (by 0.5, 1.0, and 2.0 cm) motion waveforms from single-breath four-dimensional computed tomography (4DCT) and multi-breath time-resolved 4D magnetic resonance imaging (TR-4DMRI). The planning tumor volume (PTV = ITV + 5 mm margin) dose coverage (PTV D95%) was evaluated. The repeated waveforms were used to move the isocenter in sync with the clinical leaf motion and gantry rotation. The continuous VMAT arcs were broken down into many static beam fields at the control points (2°-interval) and the composite plan represented the motion-incorporated VMAT plan. Eight motion-incorporated plans per patient were simulated and the plan with the native 4DCT waveform was used as a control. The first (D95% ≤ 95%) and second (D95% ≤ 90%) plan breaching points due to motion amplitude increase were identified and analyzed. The PTV D95% in the motion-incorporated plans was 99.4 ± 1.0% using 4DCT, closely agreeing with the corresponding ITV-based VMAT plan (PTV D95% = 100%). Tumor motion irregularities were observed in TR-4DMRI and triggered D95% ≤ 95% in one case. For small tumors, 4 mm extra motion triggered D95% ≤ 95%, and 6–8 mm triggered D95% ≤ 90%. For large tumors, 14 mm and 21 mm extra motions triggered the first and second breaching points, respectively. This study has demonstrated that PTV D95% breaching points may occur for small tumors during treatment delivery. Clinically, it is important to monitor and avoid systematic motion increase, including baseline drift, and large random motion spikes through threshold-based beam gating.
format Online
Article
Text
id pubmed-9784418
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97844182022-12-24 A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI Li, Guang Sehovic, Admir Xu, Lee Shukla, Pawas Zhang, Lei Zhou, Ying Wang, Ping Wu, Abraham Rimner, Andreas Zhang, Pengpeng J Clin Med Article As patient breathing irregularities can introduce a large uncertainty in targeting the internal tumor volume (ITV) of lung cancer patients, and thereby affect treatment quality, this study evaluates dose tolerance of tumor motion amplitude variations in ITV-based volumetric modulated arc therapy (VMAT). A motion-incorporated planning technique was employed to simulate treatment delivery of 10 lung cancer patients’ clinical VMAT plans using original and three scaling-up (by 0.5, 1.0, and 2.0 cm) motion waveforms from single-breath four-dimensional computed tomography (4DCT) and multi-breath time-resolved 4D magnetic resonance imaging (TR-4DMRI). The planning tumor volume (PTV = ITV + 5 mm margin) dose coverage (PTV D95%) was evaluated. The repeated waveforms were used to move the isocenter in sync with the clinical leaf motion and gantry rotation. The continuous VMAT arcs were broken down into many static beam fields at the control points (2°-interval) and the composite plan represented the motion-incorporated VMAT plan. Eight motion-incorporated plans per patient were simulated and the plan with the native 4DCT waveform was used as a control. The first (D95% ≤ 95%) and second (D95% ≤ 90%) plan breaching points due to motion amplitude increase were identified and analyzed. The PTV D95% in the motion-incorporated plans was 99.4 ± 1.0% using 4DCT, closely agreeing with the corresponding ITV-based VMAT plan (PTV D95% = 100%). Tumor motion irregularities were observed in TR-4DMRI and triggered D95% ≤ 95% in one case. For small tumors, 4 mm extra motion triggered D95% ≤ 95%, and 6–8 mm triggered D95% ≤ 90%. For large tumors, 14 mm and 21 mm extra motions triggered the first and second breaching points, respectively. This study has demonstrated that PTV D95% breaching points may occur for small tumors during treatment delivery. Clinically, it is important to monitor and avoid systematic motion increase, including baseline drift, and large random motion spikes through threshold-based beam gating. MDPI 2022-12-13 /pmc/articles/PMC9784418/ /pubmed/36556006 http://dx.doi.org/10.3390/jcm11247390 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Guang
Sehovic, Admir
Xu, Lee
Shukla, Pawas
Zhang, Lei
Zhou, Ying
Wang, Ping
Wu, Abraham
Rimner, Andreas
Zhang, Pengpeng
A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI
title A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI
title_full A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI
title_fullStr A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI
title_full_unstemmed A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI
title_short A Simulation Study of Tolerance of Breathing Amplitude Variations in Radiotherapy of Lung Cancer Using 4DCT and Time-Resolved 4DMRI
title_sort simulation study of tolerance of breathing amplitude variations in radiotherapy of lung cancer using 4dct and time-resolved 4dmri
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784418/
https://www.ncbi.nlm.nih.gov/pubmed/36556006
http://dx.doi.org/10.3390/jcm11247390
work_keys_str_mv AT liguang asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT sehovicadmir asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT xulee asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT shuklapawas asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT zhanglei asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT zhouying asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT wangping asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT wuabraham asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT rimnerandreas asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT zhangpengpeng asimulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT liguang simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT sehovicadmir simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT xulee simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT shuklapawas simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT zhanglei simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT zhouying simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT wangping simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT wuabraham simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT rimnerandreas simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri
AT zhangpengpeng simulationstudyoftoleranceofbreathingamplitudevariationsinradiotherapyoflungcancerusing4dctandtimeresolved4dmri